12-Month Lobbying Summary - Organization

AstraZeneca Canada Inc. / Gaby Bourbara, President

Registration Summary

Currently active - Last Updated: 2025-11-14

Who is lobbying?

AstraZeneca Canada Inc. (Address & business activities)

Gaby Bourbara, President

Government Funding

Did AstraZeneca Canada Inc. receive government funding within the last 12 months? No

Other Entities (working together for the purposes of lobbying) Information

AstraZeneca Canada Inc. is not working together with any other entity for the purpose of lobbying.

Direct Interests of the Lobbying Activity

Affiliates

AstraZeneca Canada Inc. has the following affiliates that could have a direct interest in the outcome of the lobbying activities:

AstraZeneca plc (Address information)

Other Affiliates

The activities of AstraZeneca Canada Inc. are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking

Contributors with a Direct Interest in the Outcome

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of AstraZeneca Canada Inc.:

What is being lobbied?

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Discussions with BC Government officials, organizations and elected representatives to obtain public funding for AZ's innovation pharmaceuticals and biopharmaceuticals. To encourage the BC government to recognize the importance of investments made in R&D within the province and how these investments lead to the health development of BC's health ecosystem.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Economic Development and Trade
Discussions with BC government officials/organizations and elected representative to obtain public reimbursement of AstraZeneca Canada (AZC) innovative treatments for BC Citizens that require access to these treatments, including health system resilience policy and environmental considerations in health care. These discussions will take place with BC government bodies as Pharmacare, the BC Cancer Agency and First Nations Health Authority. This will include discussions on how best to conclude Product Listing Agreement and health care delivery discussions with each of these public entities.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Health
Discussions with BC government officials/organizations and elected representative to obtain public reimbursement of AstraZeneca Canada (AZC) innovative treatments for BC Citizens that require access to these treatments. These discussions will take place with BC government funded programs such as the provincial Health Authorities including PHSA	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Hospitals
Discussions with BC government officials and organizations including elected representatives to encourage the BC government to recognize the importance of AstraZeneca Canada's and the Biopharmaceutical investments in Research and Development in BC's healthcare bioscience ecosystem, and to providing innovative approaches to management of the health care system.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Industry
Discussions with BC government officials and organizations including elected representatives to encourage the BC government to recognize the importance of AstraZeneca Canada's investments in Research and Development in BC's healthcare bioscience ecosystem, and to providing innovative approaches to management of the health care system.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Science and Technology
Discussions with BC Government officials including the Ministry of Finance , organizations and elected representatives to discuss funding for AZ's innovation pharmaceuticals and biopharmaceuticals. To encourage the BC government and various ministries to recognize the importance of investments mad in R&D within the province and how these investments lead to the health development of BC's health ecosystem.	Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Finances and Budgets
Provide supply chain availability updates on AstraZeneca Canada medicines including vaccines, deemed essential for COVID-19 acute and community care.	Development of any legislative proposal by the government of British Columbia, a Provincial entity or a member of the Legislative Assembly Development or enactment of any regulation, including the enactment of a regulation for the purposes of amending or repealing a regulation Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	COVID-19

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Who is being lobbied?

Ministries/Provincial Entities

Finance
Fraser Health Authority
Health
Interior Health Authority
Jobs and Economic Growth
Member(s) of the BC Legislative Assembly
Nisga'a Valley Health Authority
Northern Health Authority
Office of the Premier
Provincial Health Services Authority
Vancouver Coastal Health Authority
Vancouver Island Health Authority

Ministries/Provincial Entities in previous versions
- Jobs, Economic Development and Innovation
- Mental Health and Addictions
- Parliamentary Secretary for Environment

Who are the lobbyists?

In-house Lobbyists

Lobbyist

Contributions

Derek Badger
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No